-
Practice Guideline Guideline
Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
- Paul E Monahan, Louis M Aledort, and Hemophilia Inhibitor Study Group.
- Department of Pediatrics, University of North Carolina at Chapel Hill, North Carolina, USA. Paul_Monahan@med.unc.edu
- Am. J. Hematol. 2004 Dec 1; 77 (4): 346-50.
AbstractAchieving adequate hemostasis in patients with hemophilia and high-titer inhibitor antibodies remains a challenge despite the development of plasma-derived and recombinant therapies to bypass the inhibitory effect. A group of hemophilia treaters met to examine the factors that influence physician choices among the very costly and cumbersome available therapies. Specific knowledge deficits in need of prospective research were identified with respect to the rational treatment of inhibitor patients.2004 Wiley-Liss, Inc.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..